ArticleGeburtshilfe und Frauenheilkunde2018

Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis.

Philip Junker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.